The global Nephrostomy Devices market, used to restore urine flow from blocked ureters and improve kidney function, had a value of $831.8 million in 2018. It is projected to reach $1.51 billion by 2026, growing at a compound annual growth rate (CAGR) of 7.7%.
The demand for nephrostomy devices is expected to be driven by the increasing incidence of hydronephrosis. Factors such as a growing elderly population and the prevalence of ovarian and prostate cancers are also anticipated to contribute to market growth. In the United States, approximately 37 million people are affected by Chronic Kidney Disease (CKD), with 125,000 individuals starting treatment for End-stage Kidney Disease (ESKD) in 2016, either through dialysis or kidney transplant. The market is further fueled by the global aging population, as revealed by the Third National Health and Nutrition Examination, which found that nearly 40% of Americans aged 60 and older have some level of chronic kidney disease.
Get a sample of the report @https://www.reportsanddata.com/download-free-sample/2712
Companies considered and profiled in this market study
Boston Scientific Corp (U.S.), Teleflex, Inc. (U.S.), Cardinal Health (U.S.), Becton, Dickinson and Company (U.S.), Cook Medical (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark), Olympus Corp (Japan), Argon Medical (U.S.), and Uresil LLC (U.S.), are the key players of the Nephrostomy Devices market.
To know more about the report @ https://www.reportsanddata.com/report-detail/nephrostomy-devices-market
Driving Factors of the Nephrostomy Devices Market:
- Increasing Incidence of Hydronephrosis: The rising prevalence of hydronephrosis, a condition characterized by blockage in the ureters, is a significant driving factor for the nephrostomy devices market. Nephrostomy devices are crucial in restoring urine flow and normal kidney function in such cases.
- Growing Geriatric Population: The expanding elderly population globally is a major driver for the market. With age, the risk of kidney-related diseases, including chronic kidney disease and urinary tract obstructions, increases. This demographic group requires nephrostomy devices for effective management of kidney health.
- Prevalence of Ovarian and Prostate Cancers: Ovarian and prostate cancers are common types of malignancies that can lead to urinary tract blockages. The high incidence of these cancers contributes to the demand for nephrostomy devices as part of the treatment and management protocols.
- Technological Advancements: Advances in nephrostomy device technology, such as the development of minimally invasive procedures and improved catheter designs, have facilitated better patient outcomes. These technological advancements drive market growth by increasing the adoption of nephrostomy devices.
Restraints of the Nephrostomy Devices Market:
- Lack of Awareness and Accessibility: In certain regions, there may be limited awareness about nephrostomy devices and their benefits among patients and healthcare providers. Additionally, inadequate accessibility to healthcare facilities and infrastructure can hinder the adoption of nephrostomy devices.
- Potential Complications and Risks: Nephrostomy procedures, like any medical intervention, carry potential risks and complications, such as infection, bleeding, or damage to surrounding tissues. Concerns about these risks may discourage some patients and healthcare professionals from opting for nephrostomy devices.
- Cost Constraints: The cost associated with nephrostomy devices, including the devices themselves, catheters, and related procedures, can be a barrier to market growth. High costs may limit their adoption, particularly in resource-constrained healthcare settings or regions with inadequate insurance coverage.
- Alternative Treatment Options: In certain cases, alternative treatment options, such as medications, endoscopic procedures, or surgical interventions, may be considered as alternatives to nephrostomy devices. The availability of these alternatives can impact the demand for nephrostomy devices and limit market growth.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2712
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs